HY-P99807-5mg
|
MedChemexpress LLC
|
Prolgolimab [CAS 2093956-19-3]
|
|
Cancer-programmed cell death
|
|
HY-147087-10mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-100mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-25mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-5mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-50mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-1mL
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|